Equitable access to treatment is vital for older adults with Alzheimer’s and other neurodegenerative diseases, especially in long-term care. CMS’s Long-Stay Antipsychotic Medication quality measure aimed to curb inappropriate use in nursing homes, but it has also led to unintended consequences, limiting safe, effective treatment options for more than 3 million residents.A new Manatt Health report, supported by the Alliance’s Project PAUSE Coalition, explores these impacts and offers recommendations to restore equitable care. Joining us to discuss the findings are Chad Worz, CEO of the American Society of Consultant Pharmacists and Project PAUSE convener, and geriatric psychiatrist Dr. Amita Patel.